NIH Director Visits NC TraCS
How is TraCS enabling science? That was the question posed by Francis Collins, MD, director of the National Institutes of Health, when he visited the North Carolina Translational and Clinical Sciences (TraCS) Institute, May 12.

Collins’ visit was part of a series of visits to Clinical and Translational Science Awards (CTSAs). He was in Atlanta, April 14, and at Duke, May 11. This was an opportunity for TraCS to showcase the vast infrastructure and resources it has developed in the last two years to support research and highlights of the new science produced by TraCS researchers.

Read more...
 
A Needle in a Haystack
Searching for a Biomarker to Spot Pancreatic Cancer Early
A diagnosis of cancer is undoubtedly a scary thing. But if that diagnosis comes at the right time – before a tumor has become inoperable or invades other tissues in the body, for instance – it can save your life. When it comes to cancer diagnoses, pancreatic cancer is one of the deadliest because the disease is almost never discovered early enough to be treated successfully. But if it could be caught early, many of the almost thirty thousand people that die of pancreatic cancer each year in the US could actually be cured with surgery...
Read more...
 
A Numbers Game
Office Aids in Recruitment of Study Volunteers
Numbers matter. And no place is this truer than in the realm of clinical trials, where the success or failure of the testing of sometimes life-saving treatments depends largely on how many study participants sign up – and remain part of – a given study. Recruiting and retaining the research subjects needed to populate clinical trials at UNC is the aim of the Research Recruitment Office (RRO), a new entity created by the NC Translational and Clinical Sciences Institute (NC TraCS)...
Read more...
 
TraCS Takes Show on the Road
Poster Sessions Meet Researchers Where They Are
TraCS has taken to the road three times recently, holding poster sessions on the UNC campus at locations convenient to some of the researchers. The goal has been to help researchers learn more about what facilities and services the consortium and UNC's more than 60 core facilities offer. This, in turn, will help streamline and accelerate the process of clinical and translational research.
Read more...
 

Carolina KickStart News & Reminders

Commercialization Award Recipients
Rounds 1 and 2:
Enci Therapeutics
G-Zero Therapeutics
Capture Pharmaceuticals
Hibernaid
Synereca Pharmaceuticals
X-in8 Biologicals Corporation

Rounds 4, 5 & 6:
Cell Microsystems
Ironwood Material Science
Cortical Metrics
Novolipid
LotusBioEFx
NeuroGate
Qualiber
Funding Deadlines
NSF STTR
December 2, 2011

HHS/NIH SBIR/STTR
December 5, 2011

Company Inception Loan (CIL)
NC Biotechnology Center
Deadline Rolling
The North Carolina Clinical and Translational Sciences (NC TraCS) Institute is one of 60 medical research institutions working together as a national consortium to improve the way biomedical research is conducted across the country. The consortium, funded through Clinical and Translational Science Awards (CTSA), shares a common vision to reduce the time it takes for laboratory discoveries to become treatments for patients, and to engage communities in clinical research efforts. It also is fulfilling the critical need to train a new generation of clinical researchers. The CTSA program is led by the National Center for Research Resources, part of the National Institutes of Health. For more information about NC TraCS programs and services, and the UNC-CH CTSA, call us at 919.966.6022, email us at nctracs@unc.edu, or visit us online at tracs.unc.edu